<str<strong>on</strong>g>Guidel<strong>in</strong>es</str<strong>on</strong>g> <strong>on</strong> <strong>the</strong> Preventi<strong>on</strong> <strong>and</strong> C<strong>on</strong>trol <strong>of</strong> <strong>Tuberculosis</strong> <strong>in</strong> Irel<strong>and</strong> 2010HSE/HPSCunknown. In such circumstances, screen<strong>in</strong>g by chest X-ray should be c<strong>on</strong>sidered for those adults <strong>in</strong> regularc<strong>on</strong>tact with <strong>the</strong> child (e.g. childm<strong>in</strong>der, teachers).BExp<strong>and</strong><strong>in</strong>g a c<strong>on</strong>tact <strong>in</strong>vestigati<strong>on</strong>C<strong>on</strong>siderati<strong>on</strong> should be given to extend<strong>in</strong>g screen<strong>in</strong>g if <strong>the</strong>re is evidence <strong>of</strong> transmissi<strong>on</strong> based <strong>on</strong> any <strong>of</strong><strong>the</strong> follow<strong>in</strong>g:• There is an unexpectedly high rate <strong>of</strong> <strong>in</strong>fecti<strong>on</strong> or TB disease <strong>in</strong> close c<strong>on</strong>tacts (e.g. if ≥10% <strong>of</strong> closec<strong>on</strong>tacts have TB <strong>in</strong>fecti<strong>on</strong> or active disease) 51• TB disease is identified <strong>in</strong> a casual c<strong>on</strong>tact or a c<strong>on</strong>tact with low screen<strong>in</strong>g priority• Infecti<strong>on</strong> is identified <strong>in</strong> any c<strong>on</strong>tact (close/casual) under five years <strong>of</strong> age.8.5 The C<strong>on</strong>tact Trac<strong>in</strong>g InterviewA newly diagnosed patient should be <strong>in</strong>terviewed by a tra<strong>in</strong>ed member <strong>of</strong> staff <strong>in</strong> <strong>the</strong> hospital, TB cl<strong>in</strong>ic,<strong>in</strong> <strong>the</strong> patient’s home or anywhere that will ensure <strong>the</strong> patient’s privacy. Interviews should be completedas so<strong>on</strong> as possible (see table 8.2). The <strong>in</strong>terview provides an opportunity to exchange <strong>in</strong>formati<strong>on</strong>, for<strong>the</strong> patient to acquire <strong>in</strong>formati<strong>on</strong> about TB <strong>and</strong> its c<strong>on</strong>trol, <strong>and</strong> for <strong>the</strong> health pr<strong>of</strong>essi<strong>on</strong>al to learn toadapt treatment <strong>and</strong> educati<strong>on</strong> strategies to <strong>the</strong> patient’s specific requirements. The Centers for DiseaseC<strong>on</strong>trol <strong>and</strong> Preventi<strong>on</strong> (CDC) developed st<strong>and</strong>ard procedures for <strong>in</strong>terview<strong>in</strong>g TB patients <strong>in</strong> 1999. 292 Thefollow<strong>in</strong>g pr<strong>in</strong>ciples as proposed by CDC are recommended for use:1. Build<strong>in</strong>g rapport with a case is an important part <strong>of</strong> c<strong>on</strong>tact trac<strong>in</strong>g. This can be achieved byassur<strong>in</strong>g patient privacy, help<strong>in</strong>g <strong>the</strong> patient decide how to share <strong>in</strong>formati<strong>on</strong> about <strong>the</strong>ir diagnosisto c<strong>on</strong>tacts, <strong>and</strong> allow<strong>in</strong>g approximately <strong>on</strong>e hour for exchange <strong>of</strong> <strong>in</strong>formati<strong>on</strong> (depend<strong>in</strong>g <strong>on</strong> <strong>the</strong>patient’s health <strong>and</strong> endurance).2. Exchang<strong>in</strong>g <strong>in</strong>formati<strong>on</strong> should allow <strong>the</strong> <strong>in</strong>terviewer to obta<strong>in</strong> miss<strong>in</strong>g <strong>in</strong>formati<strong>on</strong> e.g. date <strong>of</strong>symptom <strong>on</strong>set, <strong>and</strong> <strong>the</strong> patient to improve <strong>the</strong>ir underst<strong>and</strong><strong>in</strong>g <strong>of</strong> disease causati<strong>on</strong>/transmissi<strong>on</strong><strong>and</strong> clarify <strong>the</strong>ir treatment plan requirements.3. Transmissi<strong>on</strong> sett<strong>in</strong>gs i.e. places <strong>the</strong> case attended while <strong>in</strong>fectious should be identified soc<strong>on</strong>tacts attend<strong>in</strong>g those venues can be identified <strong>and</strong> prioritised for screen<strong>in</strong>g based <strong>on</strong> timespent by <strong>the</strong> <strong>in</strong>dex case <strong>in</strong> those sett<strong>in</strong>gs. Topics for discussi<strong>on</strong> could <strong>in</strong>clude where <strong>the</strong> patientsworked, spent <strong>the</strong>ir leisure/recreati<strong>on</strong>al time, where <strong>the</strong>y visited, ate, spent nights, etc. The<strong>in</strong>terviewer should ask specifically about time spent <strong>in</strong> c<strong>on</strong>gregate sett<strong>in</strong>gs (e.g. schools, pris<strong>on</strong>s,hospitals/healthcare sett<strong>in</strong>gs, etc.)4. Lists <strong>of</strong> c<strong>on</strong>tacts should be made for those attend<strong>in</strong>g each potential site <strong>of</strong> transmissi<strong>on</strong>, <strong>in</strong>clud<strong>in</strong>gname <strong>of</strong> c<strong>on</strong>tact, approximate types, frequency <strong>and</strong> durati<strong>on</strong> <strong>of</strong> exposure. Recent illness am<strong>on</strong>gc<strong>on</strong>tacts should be discussed.5. Closure: The <strong>in</strong>terviewer should express appreciati<strong>on</strong> for <strong>the</strong> patient’s c<strong>on</strong>tributi<strong>on</strong>, <strong>and</strong> <strong>in</strong>dicatehow screen<strong>in</strong>g will proceed, that site visits will be c<strong>on</strong>ducted <strong>and</strong> c<strong>on</strong>fidentiality respected.6. Follow-up <strong>in</strong>terviews should be scheduled if fur<strong>the</strong>r <strong>in</strong>formati<strong>on</strong> is required.Site <strong>in</strong>vestigati<strong>on</strong>Site visits may need to be undertaken to complement <strong>in</strong>terviews. It is important that c<strong>on</strong>siderati<strong>on</strong> is givento <strong>the</strong> <strong>in</strong>dex case’s lifestyle so that places <strong>of</strong> <strong>in</strong>tense c<strong>on</strong>tact o<strong>the</strong>r than <strong>the</strong> household may be determ<strong>in</strong>ed(e.g. work or leisure sites). Site visits may add c<strong>on</strong>tacts to <strong>the</strong> list <strong>and</strong> are <strong>the</strong> most reliable source <strong>of</strong><strong>in</strong>formati<strong>on</strong> regard<strong>in</strong>g transmissi<strong>on</strong> sett<strong>in</strong>gs. 288 Physical c<strong>on</strong>diti<strong>on</strong>s at each sett<strong>in</strong>g can c<strong>on</strong>tribute totransmissi<strong>on</strong>. At c<strong>on</strong>gregate sett<strong>in</strong>gs, <strong>the</strong> size <strong>of</strong> <strong>the</strong> room(s), ventilati<strong>on</strong> system <strong>and</strong> airflow patterns shouldbe c<strong>on</strong>sidered al<strong>on</strong>g with <strong>in</strong>formati<strong>on</strong> about how l<strong>on</strong>g <strong>and</strong> how <strong>of</strong>ten <strong>the</strong> patient was <strong>in</strong> that sett<strong>in</strong>g. Failureto visit all potential sites <strong>of</strong> transmissi<strong>on</strong> has c<strong>on</strong>tributed to TB outbreaks. 293;294 Visit<strong>in</strong>g <strong>the</strong> <strong>in</strong>dex patient’sresidence is especially helpful for f<strong>in</strong>d<strong>in</strong>g children who are c<strong>on</strong>tacts. Certa<strong>in</strong> sites (e.g. c<strong>on</strong>gregate sett<strong>in</strong>gs)require special arrangements to visit. Communicati<strong>on</strong> <strong>and</strong> liais<strong>on</strong> with management <strong>in</strong> c<strong>on</strong>gregate sett<strong>in</strong>gsis an essential comp<strong>on</strong>ent <strong>of</strong> site <strong>in</strong>vestigati<strong>on</strong>. Ma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g c<strong>on</strong>fidentiality for an <strong>in</strong>dex patient can bedifficult. The <strong>in</strong>dex case should be <strong>in</strong>formed that <strong>in</strong>formati<strong>on</strong> needs to be shared with management. Everyeffort should be taken to ma<strong>in</strong>ta<strong>in</strong> patient c<strong>on</strong>fidentiality.-99-
<str<strong>on</strong>g>Guidel<strong>in</strong>es</str<strong>on</strong>g> <strong>on</strong> <strong>the</strong> Preventi<strong>on</strong> <strong>and</strong> C<strong>on</strong>trol <strong>of</strong> <strong>Tuberculosis</strong> <strong>in</strong> Irel<strong>and</strong> 2010HSE/HPSC8.6 Screen<strong>in</strong>g ToolsThe TST us<strong>in</strong>g <strong>the</strong> Mantoux technique (2TU) is <strong>the</strong> primary tool used <strong>in</strong> c<strong>on</strong>tact trac<strong>in</strong>g 295 (chapter 2). IGRAtest<strong>in</strong>g is an additi<strong>on</strong>al diagnostic method for screen<strong>in</strong>g <strong>of</strong> LTBI.Guides to evaluat<strong>in</strong>g c<strong>on</strong>tacts <strong>of</strong> active TB cases are shown <strong>in</strong> figures 8.1 (for c<strong>on</strong>tacts <strong>of</strong> active TB cases)<strong>and</strong> 8.2 (for children between four weeks <strong>and</strong> five years who are c<strong>on</strong>tacts <strong>of</strong> <strong>in</strong>fectious TB cases). Theseguidel<strong>in</strong>es do not fit every circumstance <strong>and</strong> additi<strong>on</strong>al c<strong>on</strong>siderati<strong>on</strong>s bey<strong>on</strong>d those discussed <strong>in</strong> <strong>the</strong>seguidel<strong>in</strong>es may need to be taken <strong>in</strong>to account for specific situati<strong>on</strong>s. It is important to m<strong>on</strong>itor attendance,to identify those c<strong>on</strong>tacts who fail to attend <strong>and</strong> to ensure that <strong>the</strong> c<strong>on</strong>tact’s GP is <strong>in</strong>formed <strong>of</strong> repeatedfailures to attend.In <strong>the</strong> future, <strong>the</strong> rapidly exp<strong>and</strong><strong>in</strong>g evidence base will provide more reliable <strong>in</strong>formati<strong>on</strong> <strong>on</strong> <strong>the</strong> sensitivity<strong>and</strong> specificity <strong>of</strong> IGRA tests <strong>and</strong> <strong>the</strong>ir comparability to <strong>the</strong> TST. Evidence ga<strong>the</strong>red to date suggests that<strong>the</strong> IGRA tests are at least as sensitive as <strong>the</strong> TST <strong>in</strong> diagnos<strong>in</strong>g LTBI <strong>and</strong> more specific <strong>in</strong> populati<strong>on</strong>s that<strong>in</strong>clude previously BCG vacc<strong>in</strong>ated <strong>in</strong>dividuals. However, discordant results between IGRA <strong>and</strong> <strong>the</strong> TSThave been observed, lead<strong>in</strong>g to difficulties <strong>in</strong>terpret<strong>in</strong>g <strong>the</strong> results. 60In <strong>the</strong>ory, a two-step strategy, us<strong>in</strong>g TST (with its high sensitivity) followed by IGRA test<strong>in</strong>g (with its highspecificity) should be an optimal approach for screen<strong>in</strong>g an <strong>in</strong>dividual exposed to a TB case. 26 The chestX-ray is generally reserved as a means <strong>of</strong> c<strong>on</strong>firm<strong>in</strong>g pulm<strong>on</strong>ary disease follow<strong>in</strong>g recent c<strong>on</strong>tact with TB or<strong>in</strong> <strong>the</strong> presence <strong>of</strong> suggestive symptoms.Canadian guidel<strong>in</strong>es 60;296 <strong>on</strong> IGRA published <strong>in</strong> 2007 <strong>and</strong> updated <strong>in</strong> 2008 summarised current evidence <strong>in</strong><strong>the</strong> c<strong>on</strong>text <strong>of</strong> c<strong>on</strong>tacts <strong>of</strong> a case <strong>of</strong> <strong>in</strong>fectious TB <strong>and</strong> IGRA use as follows:• IGRA correlated with exposure better than TST <strong>in</strong> BCG vacc<strong>in</strong>ated c<strong>on</strong>tacts. There weresignificantly fewer positive results <strong>in</strong> low-exposure groups with <strong>the</strong> IGRA than with <strong>the</strong> TST• In <strong>the</strong> absence <strong>of</strong> BCG, <strong>the</strong> IGRA <strong>and</strong> TST appeared to have similar rates <strong>of</strong> positivity, although<strong>the</strong>re were discordant results.Those guidel<strong>in</strong>es c<strong>on</strong>clude that, given that several studies have found significant discordance between TST<strong>and</strong> IGRA results (both TST positive/IGRA negative <strong>and</strong> <strong>the</strong> reverse) <strong>and</strong> because <strong>the</strong> biological basis <strong>of</strong> thisdiscordance is uncerta<strong>in</strong>, <strong>the</strong> reliance <strong>on</strong> IGRA should depend <strong>on</strong> <strong>the</strong> cl<strong>in</strong>ical c<strong>on</strong>text.The Canadian guidance with regard to IGRA use <strong>in</strong> c<strong>on</strong>tact trac<strong>in</strong>g is recommended.Canadian guidance <strong>on</strong> IGRA for adult <strong>and</strong> child c<strong>on</strong>tacts <strong>of</strong> a case <strong>of</strong> active <strong>in</strong>fectious TBtuberculosis 60IGRA may be used as a c<strong>on</strong>firmatory test for a positive TST <strong>in</strong> c<strong>on</strong>tacts (adult or child) who <strong>on</strong><strong>the</strong> basis <strong>of</strong> an assessment <strong>of</strong> <strong>the</strong> durati<strong>on</strong> <strong>and</strong> degree <strong>of</strong> c<strong>on</strong>tact with an active <strong>in</strong>fectious caseare felt to have a low pre-test probability <strong>of</strong> recently acquired LTBI <strong>and</strong> who have no o<strong>the</strong>rhigh or <strong>in</strong>creased risk factors for progressi<strong>on</strong> to active disease if <strong>in</strong>fected.For close c<strong>on</strong>tacts or those c<strong>on</strong>tacts who have high or <strong>in</strong>creased risk <strong>of</strong> progressi<strong>on</strong> to activedisease if <strong>in</strong>fected, a TST (or both TST <strong>and</strong> IGRA) should be used <strong>and</strong> if ei<strong>the</strong>r is positive <strong>the</strong>c<strong>on</strong>tact should be c<strong>on</strong>sidered to have LTBI.If both TST <strong>and</strong> IGRA test<strong>in</strong>g will be used, it is recommended that blood be drawn for IGRA <strong>on</strong>or before <strong>the</strong> day when <strong>the</strong> TST is read.Repeat<strong>in</strong>g TST <strong>in</strong> c<strong>on</strong>tact <strong>in</strong>vestigati<strong>on</strong>sThe <strong>in</strong>terval between acquisiti<strong>on</strong> <strong>of</strong> <strong>in</strong>fecti<strong>on</strong> <strong>and</strong> tubercul<strong>in</strong> c<strong>on</strong>versi<strong>on</strong> is an important issue. Thisdeterm<strong>in</strong>es <strong>the</strong> <strong>in</strong>terval between <strong>the</strong> first <strong>and</strong> sec<strong>on</strong>d TST <strong>in</strong> c<strong>on</strong>tact <strong>in</strong>vestigati<strong>on</strong>s i.e. <strong>the</strong> so-calledw<strong>in</strong>dow period. Traditi<strong>on</strong>ally this had been c<strong>on</strong>sidered to be 12 weeks but all available evidence from-100-